Analysts expect Relay Therapeutics, Inc. to report revenue of 1.58 M for Q3 26, against a range of 1.45 M to 1.71 M. The most recent reported quarter, Q2 26, came in at 350,000.00, a 64.4% miss against the 981,830.40 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 7.68 M | 700,000.00 | 0.00 | 7.00 M | 3.00 M | 350,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 91,766.21 | 6.16 M | 15,193.12 | 83,470.24 | 164,509.91 | 5.61 M | 5.84 M | 1.07 M | 1.71 M | 7.41 M | 764,857.04 | 815,057.91 | 2.36 M | 9.13 M | 6.05 M | 3.32 M | ||||||||||
| Low Estimate | 78,459.03 | 5.21 M | 12,697.68 | 73,327.76 | 138,374.89 | 5.01 M | 4.91 M | 893,853.49 | 1.45 M | 6.42 M | 683,796.20 | 680,916.85 | 2.08 M | 8.56 M | 5.37 M | 2.95 M | ||||||||||
| Consensus Estimate | 85,112.62 | 5.69 M | 13,945.40 | 78,399.00 | 151,442.40 | 5.31 M | 5.38 M | 981,830.40 | 1.58 M | 6.92 M | 724,326.62 | 747,987.38 | 2.22 M | 8.84 M | 5.71 M | 3.13 M |
Analysts expect Relay Therapeutics, Inc. to report earnings per share of -0.39 for Q3 26, against a range of -0.40 to -0.38. The most recent reported quarter, Q2 26, came in at -0.41, a 10.8% miss against the -0.37 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.63 | -0.45 | -0.46 | -0.41 | -0.43 | -0.32 | -0.41 | -0.41 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.77 | -0.51 | -0.44 | -0.45 | -0.41 | -0.39 | -0.31 | -0.35 | -0.38 | -0.36 | -0.36 | -0.37 | -0.34 | -0.32 | -0.42 | -0.39 | ||||||||||
| Low Estimate | -0.87 | -0.55 | -0.48 | -0.49 | -0.49 | -0.43 | -0.37 | -0.39 | -0.40 | -0.38 | -0.42 | -0.41 | -0.38 | -0.38 | -0.50 | -0.43 | ||||||||||
| Consensus Estimate | -0.82 | -0.53 | -0.46 | -0.47 | -0.45 | -0.41 | -0.34 | -0.37 | -0.39 | -0.37 | -0.39 | -0.39 | -0.36 | -0.35 | -0.46 | -0.41 |
Pull Wall Street consensus for Relay Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RLAY&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RLAY", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RLAY&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();